Lung Cancer News and Research

Latest Lung Cancer News and Research

Dana-Farber Cancer Institute to create Chen-Huang Center for EGFR Mutant Lung Cancers

Dana-Farber Cancer Institute will create the Chen-Huang Center for EGFR (epidermal growth factor receptor) Mutant Lung Cancers to stimulate research, promote clinical trials, and strengthen the Institute's capabilities for studying and treating lung cancer.

7 Jan 2020

Can FDA-approved flu shots be repurposed as treatments for cancer?

Changing the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and clinical studies including the most recent use of checkpoint inhibitory antibodies.

7 Jan 2020

Novel imaging technique produces accurate, real-time intraoperative diagnosis of brain tumors

A novel method of combining advanced optical imaging with an artificial intelligence algorithm produces accurate, real-time intraoperative diagnosis of brain tumors, a new study finds.

6 Jan 2020

STS deeply disappointed as FDA's new ban fails to clear all flavored e-cigarettes

The Society of Thoracic Surgeons is deeply disappointed that a proposed rule authorizing a nationwide ban of flavored electronic cigarettes (e-cigarettes) did not include menthol.

3 Jan 2020

Exposure to air pollution associated with poor bone health

Some of the effects of air pollution on health are well documented -lung cancer, stroke, respiratory diseases, and a long etcetera- but for others there is less scientific evidence.

3 Jan 2020

A reality check on artificial intelligence: Are health care claims overblown?

Health products powered by artificial intelligence, or AI, are streaming into our lives, from virtual doctor apps to wearable sensors and drugstore chatbots.

30 Dec 2019

Scientists discover potential drug compounds that target common type of liver cancer

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore, and the Agency for Science, Technology and Research (A*STAR)'s Genome Institute of Singapore have discovered four potential drug compounds that target hepatocellular carcinoma, the most common type of liver cancer.

30 Dec 2019

Proton therapy reduces the relative risk of side effects for cancer patients

Proton therapy leads to significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared with traditional radiation, while cure rates between the two groups are almost identical.

26 Dec 2019

High BMI may improve the chance of survival in certain cancers

Above average or high BMI - often linked to cancers, diabetes, cardiovascular and other diseases - may in some cases improve the chance of survival among certain cancers, new research from Flinders University indicates.

26 Dec 2019

Synthetic mRNA nanoparticles restore tumor suppressor gene, make cancer cells susceptible to drugs

In preclinical experiments, investigators restored p53 using synthetic mRNA nanoparticles, making lung and liver cancer cells susceptible to available cancer drugs.

23 Dec 2019

National veteran dataset will help dissect the relationship between mental illness and prostate cancer

There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both.

23 Dec 2019

Kobe scientists develop mathematical model to predict cancer drug side effects

A research team at Kobe University Hospital have further illuminated the likelihood of cancer drug side effects that can occur due to genetic mutations in the drug-metabolizing enzyme.

20 Dec 2019

Worksite intervention can help address lung cancer disparity in rural Kentucky

Lung cancer is the leading cause of cancer deaths among all Kentuckians. Male Kentuckians have higher rates than females, with a disproportionate number residing in rural and medically underserved parts of the state.

20 Dec 2019

Common immune cell linked to failure of checkpoint inhibitors in lung cancer patients

For many lung cancer patients, the best treatment options involve checkpoint inhibitors. These drugs unleash a patient's immune system against their disease and can yield dramatic results, even in advanced cancers.

19 Dec 2019

Scientists create new classification system for tumors

Based on the largest study of cancer patients of its kind, scientists have created a new way of classifying tumors.

19 Dec 2019

Study finds air pollution increases suicide risk and depression

Cutting air pollution could significantly reduce global rates of depression, a new study finds.

18 Dec 2019

Study: Chemoradiation regimen for Stage III NSCLC is better than two tested alternatives

Lung cancer is the leading cause of cancer death in the United States and approximately 75-80% of all cases are non-small cell lung cancer (NSCLC).

17 Dec 2019

African-Americans at higher risk for cancer-associated VTE, study finds

African-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

16 Dec 2019

New tool gives more reliable and precise results in cancer research

Every cell contains a vast number of proteins, each of which has a specific function, for example as a receptor for another molecule or an enzyme that catalyzes chemical reactions.

16 Dec 2019

Novel drug shows efficacy against advanced ROS1 and NTRK fusion-positive NSCLC

Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small cell lung cancers (NSCLC).

14 Dec 2019

Lung Cancer News and Research

Latest Lung Cancer News and Research

Dana-Farber Cancer Institute to create Chen-Huang Center for EGFR Mutant Lung Cancers

Can FDA-approved flu shots be repurposed as treatments for cancer?

Novel imaging technique produces accurate, real-time intraoperative diagnosis of brain tumors

STS deeply disappointed as FDA's new ban fails to clear all flavored e-cigarettes

Exposure to air pollution associated with poor bone health

A reality check on artificial intelligence: Are health care claims overblown?

Scientists discover potential drug compounds that target common type of liver cancer

Proton therapy reduces the relative risk of side effects for cancer patients

High BMI may improve the chance of survival in certain cancers

Synthetic mRNA nanoparticles restore tumor suppressor gene, make cancer cells susceptible to drugs

National veteran dataset will help dissect the relationship between mental illness and prostate cancer

Kobe scientists develop mathematical model to predict cancer drug side effects

Worksite intervention can help address lung cancer disparity in rural Kentucky

Common immune cell linked to failure of checkpoint inhibitors in lung cancer patients

Scientists create new classification system for tumors

Study finds air pollution increases suicide risk and depression

Study: Chemoradiation regimen for Stage III NSCLC is better than two tested alternatives

African-Americans at higher risk for cancer-associated VTE, study finds

New tool gives more reliable and precise results in cancer research

Novel drug shows efficacy against advanced ROS1 and NTRK fusion-positive NSCLC

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in